OREX performance

Performance of the OREX stock (OREXIGEN THERAPEUTICS) versus S&P 500 Index(^SPX)

Loading the OREX performance compared to the performance of the S&P 500 Index ...

MARKETVOLUME®

www.MarketVolume.com

OREX Stock and Index Performance

Technical Analysis - OREXIGEN THERAPEUTICS (Stock Symbol: OREX)

OREX Stock's Performance
     

The performance tables below will allow you to compare the performance of the OREXIGEN THERAPEUTICS (OREX) stock and the S&P 500 Index(^SPX) (you may select other index from the list below). We provide performance comparison for the most recent trading session, for the past month (30 days) for 52 weeks (1-year) and YTD.

Several timeframes help evaluating whether current OREX stock's performance is in the range of the average yearly, monthly or YTD performance. The "Ratio (%)" is calculated as a ration between SPX index and OREX stock data. Since SPX index and OREX stock prices are in different range the "Ratio (%)" helps to compare SPX index and OREX stock performances. At the same time the "Ratio (%)" allows to see what percentage of index's volume (if OREX stock is listed in the SPX index) belongs to the OREX stock.

OREX ChartsOREX QuotesOREX AnalysisOREX Price
Calculators		OREX Volume
Calculators		OREX Volatility
Calculators
Compare and OREXIGEN THERAPEUTICS (OREX) stock.

Today's Performance Comparison:
S&P 500 Index(^SPX) vs OREXIGEN THERAPEUTICS (OREX)

 Delayed Quotes - U.S. Market close in 3 hours.
S&P 500 Index(^SPX)OREXIGEN THERAPEUTICS (OREX)Ratio (%)
Last Trade1,651.78 Last Trade6.380.39
Trade Time (ET)06/19/2013 12:38Trade Time (ET)06/19/2013 12:38
Change12.70(0.77%) Change0.10(1.59%)0.79
Previous Close1,639.08 Previous Close6.280.38
Open1,639.77 Open6.280.38
High1,654.19 High6.450.39
Low1,639.77 Low6.210.38
VolumeSign Up K Volume588 K

1-Month Performance Comparison:
S&P 500 Index(^SPX) vs OREXIGEN THERAPEUTICS (OREX)

S&P 500 Index(^SPX)OREXIGEN THERAPEUTICS (OREX)Ratio (%)
1-month Change14.29(0.86%) 1-month Change0.34(5.63%)-2.38
1-month High1,687.18 1-month High7.340.44
1-month Low1,598.23 1-month Low5.970.37
Average Daily VolumeSign Up K Average Daily Volume1,149 K
Average Daily Change0.70 % Average Daily Change2.02 %290.53

YTD Performance Comparison:
S&P 500 Index(^SPX) vs OREXIGEN THERAPEUTICS (OREX)

S&P 500 Index(^SPX)OREXIGEN THERAPEUTICS (OREX)Ratio (%)
YTD Change225.44(15.81%) YTD Change1.13(21.52%)0.50
YTD High1,687.18 YTD High7.340.44
YTD Low1,426.19 YTD Low4.980.35
Average Daily VolumeSign Up K Average Daily Volume1,215 K
Average Daily Change0.55 % Average Daily Change2.18 %396.74

52-week (1 year) Performance Comparison:
S&P 500 Index(^SPX) vs OREXIGEN THERAPEUTICS (OREX)

S&P 500 Index(^SPX)OREXIGEN THERAPEUTICS (OREX)Ratio (%)
52-week Change306.95(22.82%) 52-week Change2.29(55.99%)0.75
52-week High1,687.18 52-week High7.730.46
52-week Low1,309.27 52-week Low3.760.29
Average Daily VolumeSign Up K Average Daily Volume2,169 K
Average Daily Change0.58 % Average Daily Change2.85 %495.42

S&P 500 Index(^SPX) and OREXIGEN THERAPEUTICS (OREX) aligned chart.

OREXIGEN THERAPEUTICS (OREX) and S&P 500 Index(^SPX) Comparison Flash Graph

OREXIGEN THERAPEUTICS (OREX) vs S&P 500 Index(^SPX) performance.

OREXIGEN THERAPEUTICS (OREX) vs S&P 500 Index(^SPX) Performance Flash Graph
 
About S&P 500 Index(^SPX)

The S&P 500 ("Standard & Poor's 500 Stock Index") is widely regarded as the standard for measuring large-cap U.S. stock market performance. This is one of the most popular indexes representing the top 500 companies in leading industries (most of them listed on the New York Stock Exchange).		   About OREXIGEN THERAPEUTICS (OREX)

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The company's Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.
 
Copyright © 1997-2013 MarketVolume.com: You may not copy, distribute, transmit, display, perform, reproduce, publish, license, sublicense, create derivative works from, transfer or sell any of the Information. More...
  Close this Window
Close

You are logged Out of the Members' Area

To have access to real-time quotes, charts, trading signals and fresh market outlook you have to be logged in:

Not a member yet?
Click here to become a full member of MarketVolume® and enjoy the benefits of a feature rich market timing system!

No, Thanks, I would like to check the website first.

Close this Window
Disclaimer | Privacy © 1997-2013 Highlight Investments Group. All Rights Reserved. / SV1

© 1997-2013 www.MarketVolume.com. All Rights Reserved.